Zur Seitenansicht


A proposal for a new PhD level curriculum on quantitative methods for drug development
Verfasser / VerfasserinKoenig, Franz ; Jaki, T. ; Gordon, A. ; Forster, P. ; Bijnens, L. ; Bornkamp, B. ; Brannath, W. ; Fontana, R. ; Gasparini, M. ; Hampson, L.V. ; Jacobs, T. ; Jones, B. ; Paoletti, X. ; Posch, M. ; Titman, A. ; Vonk, R.
Erschienen in
Pharmaceutical Statistics, 2018, Jg. 17, H. 5, S. 593-606
ErschienenWiley-Blackwell, 2018
DokumenttypAufsatz in einer Zeitschrift
Schlagwörter (EN)evelopment of earlystage researchers / drug development / PhD curriculum / regulatory statistics / universityindustry partnership
URNurn:nbn:at:at-ubmuw:3-213 Persistent Identifier (URN)
 Das Werk ist frei verfügbar
A proposal for a new PhD level curriculum on quantitative methods for drug development [0.18 mb]
Zusammenfassung (Englisch)

This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commissionfunded network bringing together leading academic institutions and small to largesized pharmaceutical companies to train a cohort of graduatelevel medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 earlystage researchers for 36 months. IDEAS training activities are composed of a wellrounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.

Das PDF-Dokument wurde 4 mal heruntergeladen.
CC-BY-Lizenz (4.0)Creative Commons Namensnennung 4.0 International Lizenz